Detalhe da pesquisa
1.
Investigating risk factors and treatment options for severe, partially steroid responsive, and steroid-refractory checkpoint inhibitor pneumonitis.
Oncologist
; 2024 Jun 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38886156
2.
Novel endoscopic scoring system for immune mediated colitis: a multicenter retrospective study of 674 patients.
Gastrointest Endosc
; 2024 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38272276
3.
Decoupling FcRn and tumor contributions to elevated immune checkpoint inhibitor clearance in cancer cachexia.
Pharmacol Res
; 199: 107048, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38145833
4.
Response to Dabrafenib Plus Trametinib in a Patient With an Uncommon Activating BRAF Mutation: A First in Non-Small Cell Lung Cancer.
J Natl Compr Canc Netw
; 22(3)2024 03 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38479107
5.
Non-Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology
J Natl Compr Canc Netw
; 22(4): 249-274, 2024 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38754467
6.
Risk Factors for Immune Checkpoint Inhibitor Immunotherapy Toxicity Among Older Adults with Cancer.
Oncologist
; 28(8): e625-e632, 2023 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37085156
7.
Association between pre-treatment chest imaging and pulmonary function abnormalities and immune checkpoint inhibitor pneumonitis.
Cancer Immunol Immunother
; 72(6): 1727-1735, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36640189
8.
Association of medical comorbidities and cardiovascular disease with toxicity and survival among patients receiving checkpoint inhibitor immunotherapy.
Cancer Immunol Immunother
; 72(7): 2005-2013, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36738310
9.
Mean platelet volume, thrombocytosis, and survival in non-small cell lung cancer patients treated with first-line pembrolizumab alone or with chemotherapy.
Cancer Immunol Immunother
; 72(7): 2067-2074, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36795122
10.
Association Between Pretreatment Chest Imaging and Immune Checkpoint Inhibitor Pneumonitis Among Patients With Lung Cancer.
J Natl Compr Canc Netw
; 21(11): 1164-1171.e5, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37935100
11.
Metabolic Dysregulation Explains the Diverse Impacts of Obesity in Males and Females with Gastrointestinal Cancers.
Int J Mol Sci
; 24(13)2023 Jun 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37446025
12.
Immune checkpoint inhibitor-related thrombocytopenia: incidence, risk factors and effect on survival.
Cancer Immunol Immunother
; 71(5): 1157-1165, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-34618180
13.
The Neonatal Fc Receptor Is Elevated in Monocyte-Derived Immune Cells in Pancreatic Cancer.
Int J Mol Sci
; 23(13)2022 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35806069
14.
Comparative assessment of manual chart review and ICD claims data in evaluating immunotherapy-related adverse events.
Cancer Immunol Immunother
; 70(10): 2761-2769, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33625533
15.
Harmonized Outcome Measures for Use in Non-Small Cell Lung Cancer Patient Registries and Clinical Practice.
J Natl Compr Canc Netw
; 2021 Aug 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34388732
16.
Bone Metastases, Skeletal-Related Events, and Survival in Patients With Metastatic Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors.
J Natl Compr Canc Netw
; 19(8): 915-921, 2021 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33878726
17.
Brief report: inhaled corticosteroid use and the risk of checkpoint inhibitor pneumonitis in patients with advanced cancer.
Cancer Immunol Immunother
; 69(11): 2403-2408, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32728772
18.
Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort.
Cancer Immunol Immunother
; 69(7): 1177-1187, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32140762
19.
Correction to: Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort.
Cancer Immunol Immunother
; 69(7): 1189, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32347358
20.
Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: causal modeling, timing, and classes of concomitant medications.
BMC Cancer
; 20(1): 383, 2020 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32375706